promethazine/sumatriptan (CL-H1T)
/ Charleston Labs
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
November 11, 2019
A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain
(clinicaltrials.gov)
- P2; N=475; Completed; Sponsor: Charleston Laboratories, Inc; Recruiting ➔ Completed
Clinical • Trial completion
March 18, 2019
A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain
(clinicaltrials.gov)
- P2; N=400; Recruiting; Sponsor: Charleston Laboratories, Inc
Clinical • New P2 trial
1 to 2
Of
2
Go to page
1